POZEN announces positive results from Phase 3 trials of PA32540 – Yahoo Finance

POZEN announced positive top-line results from two randomized, double-blind, multi-center, pivotal Phase 3 clinical trials of PA32540, a novel, coordinated-delivery tablet of immediate-release omeprazole and delayed release aspirin. Detailed …

Leave a Reply

Your email address will not be published. Required fields are marked *